Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Therapeutic leukapharesis in pediatric leukemia: Utilization trend and early outcomes in a US Nationwide Cohort (Takahashi T et cl. J Pediatr Hematol Oncol, March 2022)

Therapeutic leukapharesis in pediatric leukemia: Utilization trend and early outcomes in a US Nationwide Cohort
Takahashi T et cl. J Pediatr Hematol Oncol, March 2022

Link to full abstract

 

 

Design and stability of pediatric oral formulation of imatinib (Hinterlang M et al. J Oncol Pharm Pract, March 2022)

Design and stability of pediatric oral formulation of imatinib
Hinterlang M et al. J Oncol Pharm Pract, March 2022

Link to full abstract

 

 

Comparison of the transcriptomic signature in pediatric and adult CML (Youn M et al. Cancers(Basel), December 2021)

Comparison of the transcriptomic signature in pediatric and adult CML
Youn M et al. Cancers(Basel), December 2021 – open access publication

Link to full abstract

 

 

Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML (Smith SM et al. Pediatr Hematol Oncol, December 2021)

Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML
Smith SM et al. Pediatr Hematol Oncol, December 2021 (epub ahead of print)

Link to full abstract

 

 

Efficacy of ponatinib prior to and after allogeneic hematopoietic stem cell transplantation in an adolescent with chronic myeloid leukemia in blast phase (Lee JW et al. Blood Res, November 2021)

Efficacy of ponatinib prior to and after allogeneic hematopoietic stem cell transplantation in an adolescent with chronic myeloid leukemia in blast phase
Lee JW et al. Blood Res, November 2021

Link to full abstract

 

 

  1. Seven year long follow-up of patient with childhood chronic myeloid leukemia postsecond haploidentical stem cell transplant (Sachdev M et al. J Pediatr Hematol Oncol, November 2021)
  2. Pediatric chronic myeloid leukemia presenting with extreme thrombocytosis and acute upper gastrointestinal haemorrhage: A case report (Zhang Y et al. J Pediatr Hematol Oncol, Oct 2021)
  3. Chronic myeloid leukemia in children: immune function and vaccinations (Suttorp M et al. J Clin Med, September 2021)
  4. Discontinuation of imatinib in children with chronic myeloid leukemia: A study from the International Registry of Childhood CML (Millot F et al. Cancers(Basel), August 2021